What lab work is recommended for a patient suspected of having Polycystic Ovary Syndrome (PCOS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Workup for Suspected PCOS

For suspected PCOS, order total or free testosterone (preferably by LC-MS/MS), TSH, prolactin, a 2-hour 75g oral glucose tolerance test, and a fasting lipid panel as your core initial laboratory evaluation. 1, 2, 3

First-Line Hormonal Tests

Androgen Assessment

  • Measure total testosterone (TT) or free testosterone (FT) as your primary androgen markers using liquid chromatography-tandem mass spectrometry (LC-MS/MS), which demonstrates superior specificity (92%) compared to direct immunoassays (78%). 1
  • Total testosterone shows pooled sensitivity of 74% and specificity of 86%, while free testosterone demonstrates superior sensitivity of 89% with specificity of 83%. 1
  • If LC-MS/MS is unavailable, calculate Free Androgen Index (FAI) using total testosterone and sex hormone-binding globulin (SHBG) as an alternative. 1

Exclusion of Other Endocrine Disorders

  • Measure thyroid-stimulating hormone (TSH) to rule out thyroid disease as a cause of menstrual irregularity. 1, 2, 3
  • Measure prolactin using morning resting serum levels to exclude hyperprolactinemia, with levels >20 μg/L considered abnormal. 1, 3

Mandatory Metabolic Screening

All women with suspected PCOS require metabolic screening regardless of body weight or BMI, as insulin resistance and metabolic dysfunction occur independently of obesity. 2, 4

Glucose Metabolism

  • Perform a 2-hour oral glucose tolerance test with 75g glucose load—this is superior to hemoglobin A1C or fasting glucose alone for detecting impaired glucose tolerance in PCOS. 1, 2, 3
  • Women with PCOS have substantially higher rates of insulin resistance, impaired glucose tolerance, and type 2 diabetes compared to women without the condition. 4, 5

Lipid Assessment

  • Order a fasting lipid panel including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. 1, 2, 3

Anthropometric Measurements

  • Calculate body mass index (BMI) and measure waist-hip ratio to identify central obesity, with WHR >0.9 indicating truncal obesity. 1, 2, 3

Second-Line Androgen Tests (If Clinical Suspicion Remains High)

  • If total testosterone and free testosterone are normal but clinical suspicion persists, measure androstenedione (A4), which has sensitivity of 75% and specificity of 71%. 1
  • Measure DHEAS (dehydroepiandrosterone sulfate) if A4 is also needed, with sensitivity of 75% and specificity of 67%—but recognize these have poorer specificity than TT/FT and should only serve as adjunctive tests. 1
  • Measure 17-hydroxyprogesterone to exclude non-classical congenital adrenal hyperplasia, particularly if DHEAS is elevated. 1, 2

Additional Tests for Specific Clinical Scenarios

When Evaluating Ovulatory Function

  • Measure luteinizing hormone (LH) and follicle-stimulating hormone (FSH) between days 3-6 of the menstrual cycle, with an LH/FSH ratio >2 suggesting PCOS—though this is abnormal in only 35-44% of women with PCOS, making it a poor standalone diagnostic marker. 1
  • Measure progesterone in the mid-luteal phase to confirm anovulation, with levels <6 nmol/L indicating anovulation. 1

When Excluding Other Causes of Hyperandrogenism

  • Consider dexamethasone suppression test if the patient has buffalo hump, moon facies, hypertension, abdominal striae, central fat distribution, easy bruising, or proximal myopathies to exclude Cushing's syndrome. 1, 2, 3
  • Evaluate for androgen-secreting tumors if there is rapid onset of symptoms, severe hirsutism, or very high testosterone levels (testosterone >150-200 ng/dL warrants immediate evaluation). 1, 3, 6

Important Clinical Pitfalls

  • Recognize that 30% of women with confirmed PCOS have normal testosterone levels, so the absence of biochemical hyperandrogenism does not exclude PCOS if clinical hyperandrogenism (hirsutism, acne, alopecia) and irregular cycles are present. 1
  • Do not use serum Anti-Müllerian Hormone (AMH) as a single diagnostic test or as an alternative for detecting polycystic ovarian morphology, despite its high sensitivity (92%) and specificity (97%), as it requires further validation and assay standardization. 1, 2, 3
  • Avoid using LH/FSH ratio as a primary diagnostic tool, as it is abnormal in only 35-44% of PCOS cases. 1
  • Direct immunoassays for testosterone have significantly lower specificity (78%) compared to LC-MS/MS (92%), potentially leading to false positives—insist on LC-MS/MS when available. 1

Diagnostic Algorithm Summary

  1. First step: Measure TT or FT using LC-MS/MS, TSH, and prolactin. 1, 3
  2. Second step: If TT/FT normal but clinical suspicion high, measure A4 and DHEAS. 1
  3. Concurrent metabolic screening: Order 2-hour OGTT and fasting lipid panel for all patients regardless of BMI. 1, 2, 3
  4. Additional exclusion tests: Measure 17-hydroxyprogesterone if DHEAS elevated; consider dexamethasone suppression test if Cushing's features present. 1, 2

References

Guideline

Laboratory Evaluations for Suspected Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis of Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Workup for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Polycystic Ovary Syndrome.

Obstetrics and gynecology, 2018

Research

Diagnosis and Treatment of Polycystic Ovary Syndrome.

American family physician, 2016

Related Questions

What laboratory tests should be obtained in a woman being evaluated for suspected polycystic ovary syndrome?
What laboratory tests are recommended for a patient suspected of having Polycystic Ovary Syndrome (PCOS)?
What screening tests should be ordered for a 21‑year‑old female with obesity, irregular menses, and excess axillary hair suspected of having polycystic ovary syndrome?
What additional management strategies are recommended for a patient with likely polycystic ovary syndrome (PCOS), abnormal uterine bleeding (AUB), elevated liver enzymes, BMI 29, elevated LDL, and currently on Sprintec (norgestimate and ethinyl estradiol)?
What is the recommended management for a 27-year-old female with right lower quadrant (RLQ) pain for 1 week and a history of polycystic ovary syndrome (PCOS)?
What beta blocker (beta-adrenergic blocking agent) is suitable for a patient with a history of Coronary Artery Bypass Grafting (CABG) presenting with penile curvature, likely due to Peyronie's disease?
What is the best treatment plan for a diabetic adult with an A1C of 9, currently on glipizide (glyburide) 5 mg ER daily and fluoxetine (Prozac) 40 mg, with a random blood sugar of hyperglycemia, allergic to metformin, and unable to afford GLP (glucagon-like peptide) or SGLT2 (sodium-glucose linked transporter 2) inhibitors?
Does a patient with two weeks of alprazolam (Xanax) abuse require a long benzodiazepine taper?
Is levothyroxine (thyroid hormone replacement medication) used to treat high Thyroid-Stimulating Hormone (TSH) levels or low TSH levels in patients with thyroid disorders?
What is the most appropriate approach for a patient with a pre-existing Do Not Resuscitate (DNR) order undergoing surgery?
What are the considerations for using eszopiclone (a non-benzodiazepine hypnotic agent) to treat insomnia in a patient?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.